Skip to content

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03408353
Enrollment
10000
Registered
2018-01-24
Start date
2017-09-15
Completion date
2027-04-30
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Carcinoma

Brief summary

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.

Detailed description

PRIMARY OBJECTIVES: I. To establish a longitudinal cohort (n=10,000) of women who undergo routine annual mammography screening with follow-up for at least five years for each study participant or until breast cancer diagnosis. II. To create a repository of blood specimens from the cohort to use for biomarker discovery and validation. III. To create a comprehensive integrated database of imaging, clinical data, health measurements, and questionnaire data on the study participants. OUTLINE: Participants complete questionnaires over 15-25 minutes about personal and family history of cancer, health status, breast cancer risk factors, diet, weight gain, and physical activity, and undergo collection of blood samples at baseline and then annually for 5 years. Participants also undergo standard of care mammography at baseline and then annually for 5 years.

Interventions

PROCEDUREBiospecimen Collection

Undergo collection of blood samples

PROCEDUREMammography

Undergo standard of care mammography

OTHERQuestionnaire Administration

Complete questionnaires

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Willingness to participate in the study and ability to provide informed consent * Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits * Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.

Exclusion criteria

* Current or recent (within the prior 6 months) history of breast feeding * Personal history of breast cancer (ductal breast carcinoma in situ \[DCIS\] or invasive breast cancer) * Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.

Design outcomes

Primary

MeasureTime frame
Creation of a repository of blood specimens and database of imaging, clinical data, health measurements, and questionnaire data5 years

Countries

United States

Contacts

CONTACTJessica Leung
jwleung@mdanderson.org713-745-4555
PRINCIPAL_INVESTIGATORJessica W Leung

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026